Tower Research Capital LLC (Trc) Adma Biologics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,473 shares of ADMA stock, worth $74,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,473

Previous 37,780 90.81%

Holding current value

$74,218

Previous $422,000 83.65%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.21 - $20.03 $384,581 - $687,169	-34,307 Reduced 90.81%	3,473 $69,000
Q2 2024 Aug 13, 2024	BUY	$5.98 - $11.18 $214,161 - $400,389	35,813 Added 1820.69%	37,780 $422,000
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $121,294 - $185,801	-27,567 Reduced 93.34%	1,967 $12,000
Q4 2023 Feb 13, 2024	BUY	$3.08 - $4.52 $63,546 - $93,256	20,632 Added 231.77%	29,534 $133,000
Q3 2023 Nov 14, 2023	SELL	$3.47 - $4.61 $35,154 - $46,703	-10,131 Reduced 53.23%	8,902 $31,000
Q2 2023 Aug 14, 2023	SELL	$3.12 - $4.22 $1,566 - $2,118	-502 Reduced 2.57%	19,033 $70,000
Q1 2023 May 09, 2023	BUY	$3.01 - $3.87 $32,243 - $41,455	10,712 Added 121.41%	19,535 $64,000
Q4 2022 Feb 10, 2023	SELL	$2.47 - $3.88 $35,997 - $56,547	-14,574 Reduced 62.29%	8,823 $34,000
Q3 2022 Nov 10, 2022	SELL	$2.03 - $2.86 $25,651 - $36,138	-12,636 Reduced 35.07%	23,397 $57,000
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $25,698 - $39,536	17,971 Added 99.5%	36,033 $71,000
Q1 2022 May 12, 2022	BUY	$1.28 - $1.83 $14,714 - $21,037	11,496 Added 175.08%	18,062 $33,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $7,156 - $10,899	6,566 New	6,566 $9,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $602 - $879	-533 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.07 $38,334 - $52,551	-25,387 Reduced 97.94%	533 $1,000
Q1 2021 May 17, 2021	BUY	$1.67 - $2.95 $12,570 - $22,204	7,527 Added 40.92%	25,920 $46,000
Q4 2020 Feb 16, 2021	SELL	$1.8 - $2.56 $92,619 - $131,724	-51,455 Reduced 73.67%	18,393 $35,000
Q3 2020 Nov 16, 2020	BUY	$2.04 - $3.74 $112,828 - $206,851	55,308 Added 380.39%	69,848 $167,000
Q2 2020 Aug 13, 2020	BUY	$2.42 - $3.29 $35,186 - $47,836	14,540 New	14,540 $43,000
Q1 2020 May 15, 2020	SELL	$1.5 - $4.59 $12,759 - $39,042	-8,506 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$3.89 - $5.15 $4,512 - $5,974	1,160 Added 15.79%	8,506 $34,000
Q3 2019 Nov 05, 2019	SELL	$3.19 - $5.39 $19,210 - $32,458	-6,022 Reduced 45.05%	7,346 $32,000
Q2 2019 Aug 13, 2019	BUY	$3.52 - $5.24 $46,703 - $69,524	13,268 Added 13268.0%	13,368 $52,000
Q1 2019 May 14, 2019	SELL	$2.61 - $4.35 $10,484 - $17,473	-4,017 Reduced 97.57%	100 $0
Q4 2018 Feb 14, 2019	BUY	$2.17 - $6.12 $8,879 - $25,043	4,092 Added 16368.0%	4,117 $10,000
Q3 2018 Nov 13, 2018	BUY	$4.39 - $6.85 $109 - $171	25 New	25 $0
Q4 2017 Feb 09, 2018	SELL	$2.06 - $3.24 $24,046 - $37,820	-11,673 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.76 - $3.71 $32,217 - $43,306	11,673	11,673 $36,000

Others Institutions Holding ADMA

# of Institutions

319

Shares Held

185M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $4.2B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Adma Biologics, Inc. Transaction History